The Role of the Transcription Factor SIM2 in Prostate Cancer
暂无分享,去创建一个
John M. Asara | Martin G. Sanda | M. Sanda | J. Asara | M. Arredouani | B. Lu | Bin Lu | Mohamed S. Arredouani
[1] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[2] R. Narayanan,et al. Down's syndrome-associated single minded gene as a novel tumor marker. , 2002, Anticancer Research.
[3] R. Metz,et al. Differential Transcriptional Regulation by Mouse Single-minded 2s* , 2006, Journal of Biological Chemistry.
[4] R. Narayanan,et al. Down's syndrome-associated Single Minded 2 gene as a pancreatic cancer drug therapy target. , 2003, Cancer letters.
[5] C. Li,et al. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] M. Whitelaw,et al. The HIF1α-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element , 2009, Oncogene.
[7] Yuhang Su,et al. Single minded 2-s (SIM2-s) gene is expressed in human GBM Cells and involved in GBM invasion , 2010, Cancer biology & therapy.
[8] Mitsutoshi Nakamura,et al. Prostate cancer antigen‐1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer , 2007, Cancer science.
[9] Patricia Keating,et al. Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. Antonarakis,et al. Cloning of two human homologs of the Drosophila single-minded gene SIM1 on chromosome 6q and SIM2 on 21q within the Down syndrome chromosomal region. , 1997, Genome research.
[11] R. Narayanan,et al. Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Melton,et al. "Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells , 2002, Science.
[13] J. Pelletier,et al. The murine Sim-2 gene product inhibits transcription by active repression and functional interference , 1997, Molecular and cellular biology.
[14] Giuseppe Tridente,et al. The Prostate Specific Membrane Antigen Regulates the Expression of IL-6 and CCL5 in Prostate Tumour Cells by Activating the MAPK Pathways1 , 2009, PloS one.
[15] Marie Joseph,et al. Gene Signatures of Progression and Metastasis in Renal Cell Cancer , 2005, Clinical Cancer Research.
[16] L. Cantley,et al. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Katsuki,et al. Mild impairment of learning and memory in mice overexpressing the mSim2 gene located on chromosome 16: an animal model of Down's syndrome. , 1999, Human molecular genetics.
[18] R. Metz,et al. The bHLH/PAS transcription factor singleminded 2s promotes mammary gland lactogenic differentiation , 2010, Development.
[19] D. Peehl,et al. Expression of CCL5 (RANTES) and CCR5 in prostate cancer , 2006, The Prostate.
[20] Jianguo Xia,et al. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst , 2011, Nature Protocols.
[21] David S. Wishart,et al. MetaboAnalyst: a web server for metabolomic data analysis and interpretation , 2009, Nucleic Acids Res..
[22] S. Sealfon,et al. Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. , 2002, Nucleic acids research.
[23] S. Minoshima,et al. Molecular mechanisms of human single-minded 2 (SIM2) gene expression: identification of a promoter site in the SIM2 genomic sequence. , 2001, Gene.
[24] Robert C. Burghardt,et al. Loss of Singleminded-2s in the Mouse Mammary Gland Induces an Epithelial-Mesenchymal Transition Associated with Up-Regulation of Slug and Matrix Metalloprotease 2 , 2007, Molecular and Cellular Biology.
[25] M. Bhasin,et al. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy , 2008, The Prostate.
[26] Manoj Bhasin,et al. Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer , 2009, Clinical Cancer Research.
[27] S. Cingarlini,et al. The prostate specific membrane antigen regulates the expression of IL-6 and CCL-5 in prostate tumour cells by activating the MAPK pathways , 2009 .
[28] K. Nishio,et al. Identification of expressed genes characterizing long-term survival in malignant glioma patients , 2006, Oncogene.
[29] Inge Jonassen,et al. Increased Expression of SIM2-s Protein Is a Novel Marker of Aggressive Prostate Cancer , 2007, Clinical Cancer Research.
[30] J. Pelletier,et al. Different transcriptional properties of mSim‐1 and mSim‐2 , 2000, FEBS letters.
[31] Song Jiang,et al. Toll-like receptor signaling in cell proliferation and survival. , 2010, Cytokine.
[32] R. Metz,et al. Inhibition of breast cancer growth and invasion by single-minded 2s. , 2006, Carcinogenesis.
[33] C. Zahnow,et al. Ha-Ras transformation of MCF10A cells leads to repression of Singleminded-2s through NOTCH and C/EBPβ , 2009, Oncogene.
[34] L. Cantley,et al. PI3K pathway alterations in cancer: variations on a theme , 2008, Oncogene.